Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Iberdomide, Daratumumab and Dexamethasone VS Daratumumab, Bortezomib, and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma
What's the purpose of the trial?
The goal of this clinical trial is to find the optimal dose of investigational drug iberdomide in combination with daratumumab and dexamethasone, and to study whether investigational drug iberdomide works in treating relapsed or refractory multiple myeloma when combined with daratumumab and dexamethasone.
There are 23 centers participating in this trial. Enter a location below to find the closet center.
Learn more about the experimental treatments being evaluated in this clinical trial.
Arms / Cohorts
Explore eligibility, treatments and learn more about potential cohorts.
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!